These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1226345

  • 21. [Regional distribution of ventilation and perfusion in the beginning chronic bronchopneumopathies].
    Yernault JC, Robience Y, Denaut M, De Coster A, Englert M.
    Poumon Coeur; 1975; 31(5):241-8. PubMed ID: 1226340
    [Abstract] [Full Text] [Related]

  • 22. The components of the carbon monoxide diffusing capacity in man dependent on alveolar volume.
    Stam H, Versprille A, Bogaard JM.
    Bull Eur Physiopathol Respir; 1983; 19(1):17-22. PubMed ID: 6850142
    [Abstract] [Full Text] [Related]

  • 23. Prediction of carbon monoxide diffusing capacity of the lung in splenectomized sheep.
    McNeil JS, Torrington KG, Mundie TG, Banks RA, Phillips YY, Ripple GR.
    Lab Anim Sci; 1991 Jan; 41(1):63-5. PubMed ID: 1849591
    [Abstract] [Full Text] [Related]

  • 24. Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology.
    Snider GL.
    Am Rev Respir Dis; 1989 Sep; 140(3 Pt 2):S3-8. PubMed ID: 2675711
    [Abstract] [Full Text] [Related]

  • 25. [Pulmonary diffusion test to NO and CO time course during thoracic radiotherapy for lung cancer: the CONORT prospective study protocol].
    Zarza V, Couraud S, Hassouni A, Prévost C, Souquet PJ, Letanche G, Hammou Y, Girard N, Viart-Ferber C, Mornex F.
    Cancer Radiother; 2014 Oct; 18(5-6):420-4. PubMed ID: 25205426
    [Abstract] [Full Text] [Related]

  • 26. Effect of breath-hold time on DLCO(SB) in patients with airway obstruction.
    Graham BL, Mink JT, Cotton DJ.
    J Appl Physiol (1985); 1985 Apr; 58(4):1319-25. PubMed ID: 3988686
    [Abstract] [Full Text] [Related]

  • 27. The transfer factor and its subdivisions in patients with pulmonary emboli.
    Fennerty AG, Gunawardena KA, Smith AP.
    Eur Respir J; 1988 Feb; 1(2):98-101. PubMed ID: 3360094
    [Abstract] [Full Text] [Related]

  • 28. [Measurement of diffusing capacity by the intrabreath method].
    Suzuki T, Yoshimi K, Ueki J, Fukuchi Y.
    Nihon Kokyuki Gakkai Zasshi; 2005 Jun; 43(6):347-53. PubMed ID: 15997784
    [Abstract] [Full Text] [Related]

  • 29. [Early functional disorders in 3 children exhibiting an obstructive syndrome and an alpha 1 antitrypsin deficiency].
    Gaultier C, Mensch B, Grimfeld A, Girard F, Gerbeaux J.
    Poumon Coeur; 1975 Jun; 31(5):291-5. PubMed ID: 1083978
    [Abstract] [Full Text] [Related]

  • 30. [Propagation of error, sensitivity and specificity of the CO gas transfer in various breath holding and steady state methods (author's transl)].
    Brandt HJ, Hussels M.
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():666-72. PubMed ID: 461364
    [Abstract] [Full Text] [Related]

  • 31. [Pulmonary airflow and beginning obstructive bronchopneumopathies].
    Lacoste J, Uffholtz H, Pham QT, Sentissi M, Berthet A.
    Poumon Coeur; 1975 Apr; 31(5):263-5. PubMed ID: 1226344
    [No Abstract] [Full Text] [Related]

  • 32. Clinical significance of the measurement of membrane diffusing capacity and pulmonary cappillary blood volume.
    Pande JN, Gupta SP, Guleria JS.
    Respiration; 1975 Apr; 32(5):317-24. PubMed ID: 1166137
    [Abstract] [Full Text] [Related]

  • 33. Breakdown of lung framework and an increase in pores of Kohn as initial events of emphysema and a cause of reduction in diffusing capacity.
    Yoshikawa A, Sato S, Tanaka T, Hashisako M, Kashima Y, Tsuchiya T, Yamasaki N, Nagayasu T, Yamamoto H, Fukuoka J.
    Int J Chron Obstruct Pulmon Dis; 2016 Apr; 11():2287-2294. PubMed ID: 27695315
    [Abstract] [Full Text] [Related]

  • 34. Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure.
    Agostoni P, Cattadori G, Guazzi M, Palermo P, Bussotti M, Marenzi G.
    Am Heart J; 2000 Nov; 140(5):e24. PubMed ID: 11054632
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of diffusing capacity in patients with a restrictive lung disease.
    Stam H, Splinter TA, Versprille A.
    Chest; 2000 Mar; 117(3):752-7. PubMed ID: 10713002
    [Abstract] [Full Text] [Related]

  • 36. [Pulmonary diffusing capacity in normal smoking Chinese].
    Yang SC.
    J Formos Med Assoc; 1993 Jun; 92 Suppl 2():S61-8. PubMed ID: 7904198
    [Abstract] [Full Text] [Related]

  • 37.
    Modi P, Goldin J, Cascella M.
    ; 2024 01. PubMed ID: 32310609
    [Abstract] [Full Text] [Related]

  • 38. [Pulmonary diffusing capacity for carbon monoxide during rest and following exertion in chronic obstructive ephysema].
    Patsch J.
    Wien Med Wochenschr; 1977 Jun 20; 127(12):400-1. PubMed ID: 906536
    [No Abstract] [Full Text] [Related]

  • 39. Two cases of chronic obstructive pulmonary disease with undetectable diffusing capacity for carbon monoxide.
    Ohara A, Konno S, Shimizu K, Suzuki M, Yamamoto M, Mitani A, Nishida M, Teshima T, Nishimura M.
    Respir Investig; 2021 Jan 20; 59(1):145-148. PubMed ID: 33097435
    [Abstract] [Full Text] [Related]

  • 40. Effect of body position on carbon monoxide diffusing capacity in asymptomatic smokers and nonsmokers.
    Hyland RH, Krastins IR, Aspin N, Mansell AL, Zamel N.
    Am Rev Respir Dis; 1978 Jun 20; 117(6):1045-53. PubMed ID: 666102
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.